Gene · 57007
Papers3,960
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,960
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Elevated conformational dynamics makes ACKR3 activation-prone and G protein-incompetent. | bioRxiv | 2026 | 42239441 | PubTator, text mining | PubMed |
| Pyrazolo-quinolinone suppresses epithelial-mesenchymal transition by targeting the CXCR4/NF-κB axis in human pancreatic cancer cells. | Pathol Res Pract | 2026 | 42224831 | PubTator, text mining | PubMed |
| EXPRESSION OF CONCERN: Overlapping and Distinct Role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 Axes in Regulating Metastatic Behavior of Human Rhabdomyosarcomas. | Int J Cancer | 2026 | 42219958 | PubTator, text mining | PubMed |
| Immunomodulatory crosstalk between GPCR and hippo signaling in cancer: implications for tumor immunity and therapeutic targeting. | Front Immunol | 2026 | 42199411 | PubTator, text mining | PubMed |
| Viral modulation of the CXCL12/CXCR4/CXCR7 axis: mechanisms, impacts on immunity and oncogenesis, and therapeutic opportunities. | Cancer Treat Res Commun | 2026 | 42161093 | PubTator, text mining | PubMed |
| Exploring the Chemotactic Effects of MIF on Neutrophils and T Cells and Methods for Selective Receptor Targeting. | Methods Mol Biol | 2026 | 42129120 | PubTator, text mining | PubMed |
| Association of CXCR7 and CXCR4 expression with tumor immune phenotypes in tubo-ovarian high-grade serous carcinoma. | Ir J Med Sci | 2026 | 42126757 | PubTator, text mining | PubMed |
| The CXCL12-CXCR4 axis in colorectal cancer: immune regulation, metastatic progression, and therapeutic implications. | Front Immunol | 2026 | 42112396 | PubTator, text mining | PubMed |
| Infant respiratory syncytial virus infection disrupts β2 adrenergic airway relaxation via epithelial CXCL11. | Am J Respir Crit Care Med | 2026 | 42085211 | PubTator, text mining | PubMed |
| An integrated machine learning and computational framework with experimental validation for the identification of novel CXCR4 inhibitors. | Eur J Med Chem | 2026 | 42068640 | PubTator, text mining | PubMed |
| System Pharmacology-Based Anti-proliferation and Anti-angiogenesis Mechanisms of Oridonin in Psoriasis Keratinocytes by Blocking PI3K/AKT Signaling Pathway. | Chin J Integr Med | 2026 | 42043668 | PubTator, text mining | PubMed |
| Cooperative Control of Arrestin Activation By Membrane Lipids And Phosphorylation Barcodes. | bioRxiv | 2026 | 42039491 | PubTator, text mining | PubMed |
| Pharmacological modulation of CXCL12/CXCR4/ACKR3 for brain disorders - an overview. | Cell Commun Signal | 2026 | 42026661 | PubTator, text mining | PubMed |
| CXCL12 and eotaxin are independent prognostic serum biomarkers in gastric cancer. | Sci Rep | 2026 | 41906027 | PubTator, text mining | PubMed |
| CXCR4, CXCR7 and PBRM1 are responsible for everolimus and cabozantinib resistance in human renal cancer cells. | Cell Death Discov | 2026 | 41896541 | PubTator, text mining | PubMed |
| circOMA1 delivered by exosomes regulates DRD2‑mediated prolactinoma resistance. | Int J Mol Med | 2026 | 41891968 | PubTator, text mining | PubMed |
| Beta 2 adrenergic receptor agonists as a treatment for metabolic dysfunction-associated steatohepatitis (MASH). | NPJ Metab Health Dis | 2026 | 41882076 | PubTator, text mining | PubMed |
| Olfactory immunity: defending the neural-mucosal barrier. | J Immunol | 2026 | 41876364 | PubTator, text mining | PubMed |
| Update on Congenital Cranial Dysinnervation Disorders (CCDDs). | Int Ophthalmol Clin | 2026 | 41870107 | PubTator, text mining | PubMed |
| Theranostic applications of CXCR4-targeted imaging ligands in lymphoma: integrating diagnosis and precision therapy. | Am J Nucl Med Mol Imaging | 2026 | 41868688 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57007/papers?page=2